title: Dynorphin gene expression and release in the myocardial cell.
abstract: The expression of the prodynorphin gene was investigated in adult cultured rat ventricular cardiac myocytes by using a sensitive solution hybridization RNase protection assay for the quantitative analysis of prodynorphin mRNA. Myocyte culture in high KCl resulted, after 4 h, in a marked increase in cellular prodynorphin mRNA, while a KCl treatment for 6, 12, or 24 h progressively down-regulated the levels of prodynorphin mRNA below the control value. Immunoreactive dynorphin B, a biologically active end product of the precursor, was found to be present in the culture medium in significantly higher amounts than in the cardiac myocytes. The levels of this biologically active K opioid receptor agonist significantly increased after 4 h of KCl treatment and were markedly reduced following a 24-h exposure of the cardiac myocytes to KCl. These KCl-induced effects were all abolished by cell incubation in the presence of the calcium channel blocker verapamil. In single cardiac myocytes, acute stimulation of K opioid receptors with dynorphin B or with the selective agonist U-50,488H increased the level of cytosolic calcium. This effect was abolished by the specific K opioid receptor antagonist (Mr-1452) and was not affected by the removal of calcium from the bathing medium. These results suggest that an opioid gene may influence the myocardial function in an autocrine or paracrine fashion.
authors.affiliation: Institute of Biological Chemistry A. Bonsignore, University of Sassari, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Ventura
authors.forename: C
authors.initials: C
authors.lastname: Guarnieri
authors.forename: I
authors.initials: I
authors.lastname: Vaona
authors.forename: G
authors.initials: G
authors.lastname: Campana
authors.forename: G
authors.initials: G
authors.lastname: Pintus
authors.forename: S
authors.initials: S
authors.lastname: Spampinato
mesh_terms: D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D003600:Cytosol / Q000378:metabolism; D004399:Dynorphins / Q000096:biosynthesis*; D004745:Enkephalins / Q000096:biosynthesis*; D015870:Gene Expression / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006352:Heart Ventricles; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D011498:Protein Precursors / Q000096:biosynthesis*; D011759:Pyrrolidines / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D017473:Receptors, Opioid, kappa / Q000187:drug effects / Q000502:physiology
chemical_list: D000700:Analgesics; D004745:Enkephalins; D011498:Protein Precursors; D011759:Pyrrolidines; D012333:RNA, Messenger; D017473:Receptors, Opioid, kappa; D011189:Potassium Chloride; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D004399:Dynorphins; C033660:preproenkephalin; D002118:Calcium